Premature Mortality in Patients with Addison’s Disease: A Population-Based Study
Abstract
Background: The survival rate of patients with primary adrenal insufficiency (Addison’s disease) undergoing currently accepted replacement therapy is not known, although well-informed patients are considered to have a normal survival rate. In this study, we evaluated the mortality of patients with Addison’s disease in Sweden. Methods: A population-based, retrospective, observational study was performed, using the National Swedish Hospital and Cause of Death Registers, covering the period from 1987–2001. After a diagnosis of Addison’s disease, each patient was followed until the end of follow-up or death. Mortality was compared with that of the Swedish background population. Findings: We identified 1675 patients (995 women and 680 men) diagnosed with primary adrenal insufficiency. The average follow-up from initial diagnosis was 6.5 yr. Five hundred seven patients died during the study period compared with an expected 199. The risk ratio for all-cause mortality was 2.19 (confidence interval 1.91–2.51) for men and 2.86 (confidence interval 2.54–3.20) for women. The excess mortality in both men and women was attributed to cardiovascular, malignant, and infectious diseases. Concomitant diabetes mellitus was observed in 12% of the patients, but only contributed to the increased mortality to a minor extent. Interpretation: Compared with the background population, we observed that the risk ratio for death was more than 2-fold higher in patients with Addison’s disease. Cardiovascular, malignant, and infectious diseases were responsible for the higher mortality rate.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In all these reports, adrenal crisis was a significant cause of death.
“However, in all these reports, adrenal crisis was a significant cause of death.”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [149]
The Mortality section reports 36 deaths attributed to adrenal insufficiency but explicitly says that no patient was reported to have died from adrenal crisis under ICD-10. It also cautions that ICD-9 cannot distinguish adrenal crisis from primary adrenal insufficiency, so the study does not establish crisis as a significant cause of death. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredPatients with comorbidities, notably asthma and diabetes, are more vulnerable to adrenal crisis.
“Patients with comorbidities are more vulnerable to adrenal crisis, notably those with asthma and diabetes.”
From Guidelines for the management of glucocorticoids during the peri‐operative period for patients with adrenal insufficiency (2020) · cites this paper as [19]
The Discussion reports that patients with both diabetes and primary adrenal insufficiency had a higher risk of death than those with adrenal insufficiency alone. It does not establish a higher risk of adrenal crisis, and the passages found do not identify asthma as a risk factor. The Mortality section says the study could not distinguish adrenal crisis from primary adrenal insufficiency in its ICD-9 records. (LLM, conf=0.82)
Experimental — accuracy not yet measuredPatients with mineralocorticoid or vasopressin dependency are less stable than secondary adrenal patients with intact mineralocorticoid function.
“Patients with mineralocorticoid or vasopressin dependency are also less stable than secondary adrenal patients with intact mineralocorticoid function [19].”
From Guidelines for the management of glucocorticoids during the peri‐operative period for patients with adrenal insufficiency (2020) · cites this paper as [19]
The Discussion (page unavailable) suggests that mineralocorticoid insufficiency may compromise survival in patients with primary adrenal insufficiency. It does not address vasopressin dependency or compare these patients’ stability with that of secondary adrenal patients with intact mineralocorticoid function. (LLM, conf=0.78)
Experimental — accuracy not yet measuredMortality of patients with PAI was increased in some but not all studies.
“Mortality of patients with PAI was increased in some (149, 150), but not all studies (7).”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [149]
Excess mortality in both men and women with adrenal insufficiency was attributable to cardiovascular, malignant and infectious diseases.
“Excess mortality in both men and women was attributable to cardiovascular, malignant and infectious diseases [19].”
From Guidelines for the management of glucocorticoids during the peri‐operative period for patients with adrenal insufficiency (2020) · cites this paper as [19]
In a cohort of 1675 Swedish patients with adrenal insufficiency, the all-cause mortality risk ratio was 2.19 for men and 2.86 for women, with narrow confidence intervals.
“In a cohort of 1675 Swedish patients with adrenal insuf fi ciency, the risk ratio for all-cause mortality was 2.19 for men and 2.86 for women, with narrow con fi dence intervals.”
From Guidelines for the management of glucocorticoids during the peri‐operative period for patients with adrenal insufficiency (2020) · cites this paper as [19]
Recent data from the European Adrenal Insufficiency Registry found the major causes of death in patients with adrenal insufficiency were cardiovascular disease (35%) and infection (15%).
“Recent data from the European Adrenal Insufficiency Registry8 (including both PAI and SAI patients) found the major causes of death in patients with AI were cardiovascular disease (35%) and infection (15%), supporting previous registry data for patients with PAI.9,10”
From Adrenal crisis: prevention and management in adult patients (2019) · cites this paper as [9]
Respiratory infections contribute to the increased mortality observed in patients with primary adrenal insufficiency.
“Furthermore, respiratory infections have been shown to contribute to the increased mortality observed in patients with PAI (12, 13).”
From ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency (2020) · cites this paper as [12]
Mortality rates in AI continue to be 2-fold higher than the background population despite steroid replacement.
“Novel approaches to treating AI are needed for a condition in which mortality rates continue to be 2-fold higher than the background population despite steroid replacement (Bergthorsdottir et al., 2006).”
From Modeling Congenital Adrenal Hyperplasia and Testing Interventions for Adrenal Insufficiency Using Donor-Specific Reprogrammed Cells (2018) · cites this paper as Bergthorsdottir et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602 · see citing works
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.
Breslow, N. E., & Day, N. E. (1987) · PubMed · Cited by 1,684 · see citing works
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · see citing works
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006 · see citing works
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819 · see citing works
The natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. A. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 760 · see citing works
Betterle, C., Dal Pra, C., Mantero, F., & Zanchetta, R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0466 · Cited by 758 · see citing works
Oelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737 · see citing works
Glucocorticoids and insulin resistance: old hormones, new targets
ANDREWS, R. C., & WALKER, B. R. (1999) · Clinical Science · doi:10.1042/cs0960513 · Cited by 731 · see citing works
The components of excess mortality after hip fracture
Kanis, J. A., Odén, A., Johnell, O., Laet, C. E. D. H. D., Jönsson, B., & Oglesby, A. (2003) · Bone · doi:10.1016/s8756-3282(03)00061-9 · Cited by 550 · see citing works
The effect of diet on risk of cancer
Key, T. J., Allen, N. E., Spencer, E. A., & Travis, R. C. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09958-0 · Cited by 510 · see citing works
Visceral Obesity: A “Civilization Syndrome”
Björntorp, P. (1993) · Obesity Research · doi:10.1002/j.1550-8528.1993.tb00614.x · Cited by 483 · see citing works
On the constitutional and local effects of disease of the supra-renal capsules
Addison, T. (1855) · Medical Entomology and Zoology · Cited by 437 · see citing works
Hunt, P. J., Gurnell, E. M., Huppert, F. A., Richards, C., Prevost, A. T., Wass, J. A. H., Herbert, J., & Chatterjee, V. K. K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7022 · Cited by 386 · see citing works
Svensson, J., Bengtsson, B. ‐., Rosén, T., Odén, A., & Johannsson, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031601 · Cited by 236 · see citing works
Self-citationEighty‐six cases of Addison's disease
Kong, M., & Jeffcoate, W. J. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02790.x · Cited by 224 · see citing works
High prevalence and increasing incidence of Addison's disease in western Norway
Løvås, K., & Husebye, E. S. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.t01-1-01552.x · Cited by 221 · see citing works
Eight-six Cases of Adison's Disease
Dunlop, D. (1963) · BMJ · doi:10.1136/bmj.2.5362.887 · Cited by 216 · see citing works
Is the Prevalence of Addison's Disease Underestimated?
Laureti, S., Vecchi, L., Santeusanio, F., & Falorni, A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.5.5677-7 · Cited by 211 · see citing works
Glucocorticoid replacement therapy: are patients over treated and does it matter?
Peacey, S. R., Guo, C., Robinson, A. M., Price, A., Giles, M. A., Eastell, R., & Weetman, A. P. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.780907.x · Cited by 205 · see citing works
EPIDEMIOLOGICAL AND CLINICAL PICTURE OF ADDISON'S DISEASE
Mason, A. S., Meade, T. W., Lee, J. A. H., & Morris, J. N. (1968) · The Lancet · doi:10.1016/s0140-6736(68)90948-3 · Cited by 192 · see citing works
Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus
Björnådal, L., Löfström, B., Yin, L., et al. (2002) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740252937568 · Cited by 185 · see citing works
Myhre, A. G., Undlien, D. E., Løvås, K., Uhlving, S., Nedrebø, B. G., Fougner, K. J., Trovik, T. S., Sørheim, J. I., & Husebye, E. S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8192 · Cited by 158 · see citing works
The prevalence of Addison's disease in Coventry, UK
Willis, A., & VINCE, F. P. (1997) · Postgraduate Medical Journal · doi:10.1136/pgmj.73.859.286 · Cited by 153 · see citing works
Berger, B., Stenström, G., & Sundkvist, G. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.773 · Cited by 137 · see citing works
Williams, M. R. I., Dawood, T., Ling, S., Dai, A., Lew, R., Myles, K. M., Funder, J. W., Sudhir, K., & Komesaroff, P. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031560 · Cited by 133 · see citing works
Prevalence and Incidence of Diabetes in a Swedish Community 1972–1987
Andersson, D. K. G., Svärdsudd, K., & Tibblin, G. (1991) · Diabetic Medicine · doi:10.1111/j.1464-5491.1991.tb01626.x · Cited by 121 · see citing works
Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients
Mills, J. L., Schonberger, L. B., Wysowski, D. K., Brown, P., Durako, S. J., Cox, C., Kong, F., & Fradkin, J. E. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.12.036 · Cited by 118 · see citing works
BECKER, C. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-3-432 · Cited by 100 · see citing works
Aldosterone Function in Diabetes Mellitus: Effects on Cardiovascular and Renal Disease
McFarlane, S. I., & Sowers, J. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021443 · Cited by 67 · see citing works
Addison's disease - a review of some clinical, pathological and immunological features.
NERUP, J. (1974) · PubMed · Cited by 48 · see citing works
DHEA replacement in adrenal insufficiency
Arlt, W., & Allolio, B. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030534 · Cited by 15 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- [11]11. Dunlop D 1963 Eighty-six cases of Addison's disease. Br Med J 5362:887-891
Cited by
Sorted by citations
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769 · see citing works
“Evidence Mortality of patients with PAI was increased in some (149, 150), but not all studies (7).”
BackgroundThe Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids
Oster, H., Challet, E., Ott, V., Arvat, E., de Kloet, E. R., Dijk, D.-J., Lightman, S., Vgontzas, A., & Van Cauter, E. (2017) · Endocrine Reviews · doi:10.1210/er.2015-1080 · Cited by 548 · see citing works
Glucocorticoids and cardiovascular disease
Walker, B. R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0455 · Cited by 529 · see citing works
Diagnosis and management of adrenal insufficiency
Bancos, I., Hahner, S., Tomlinson, J., & Arlt, W. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70142-1 · Cited by 467 · see citing works
Erichsen, M. M., Løvås, K., Skinningsrud, B., Wolff, A. B., Undlien, D. E., Svartberg, J., Fougner, K. J., Berg, T. J., Bollerslev, J., Mella, B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1368 · Cited by 422 · see citing works
Hahner, S., Spinnler, C., Fassnacht, M., Burger-Stritt, S., Lang, K., Milovanovic, D., Beuschlein, F., Willenberg, H. S., Quinkler, M., & Allolio, B. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3191 · Cited by 394 · see citing works
Husebye, E. S., Pearce, S. H., Krone, N. P., & Kämpe, O. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00136-7 · Cited by 378 · see citing works
Hahner, S., Loeffler, M., Bleicken, B., Drechsler, C., Milovanovic, D., Fassnacht, M., Ventz, M., Quinkler, M., & Allolio, B. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0884 · Cited by 346 · see citing works
Johannsson, G., Nilsson, A. G., Bergthorsdottir, R., Burman, P., Dahlqvist, P., Ekman, B., Engström, B. E., Olsson, T., Ragnarsson, O., Ryberg, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1926 · Cited by 329 · see citing works
Self-citationModified-release hydrocortisone to provide circadian cortisol profiles
Debono, M., Ghobadi, C., Rostami-Hodjegan, A., Huatan, H., Campbell, M. J., Newell-Price, J., Darzy, K., Merke, D. P., Arlt, W., & Ross, R. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2380 · Cited by 322 · see citing works
Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas
Debono, M., Bradburn, M., Bull, M., Harrison, B., Ross, R. J., & Newell-Price, J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3007 · Cited by 269 · see citing works
Rushworth, R. L., Torpy, D. J., & Falhammar, H. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1807486 · Cited by 262 · see citing works
Extensive expertise in endocrinology: adrenal crisis
Allolio, B. (2015) · European Journal of Endocrinology · doi:10.1530/eje-14-0824 · Cited by 251 · see citing works
Review: Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy
Chan, S., & Debono, M. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810380214 · Cited by 243 · see citing works
Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients
Bleicken, B., Ventz, M., Quinkler, M., & Hahner, S. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181db6b7a · Cited by 242 · see citing works
Erichsen, M. M., Løvås, K., Fougner, K. J., Svartberg, J., Hauge, E. R., Bollerslev, J., Berg, J. P., Mella, B., & Husebye, E. S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0550 · Cited by 240 · see citing works
Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223 · see citing works
Isidori, A. M., Venneri, M. A., Graziadio, C., Simeoli, C., Fiore, D., Hasenmajer, V., Sbardella, E., Gianfrilli, D., Pozza, C., Pasqualetti, P., et al. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30398-4 · Cited by 211 · see citing works
Sherlock, M., Reulen, R. C., Alonso, A. A., Ayuk, J., Clayton, R. N., Sheppard, M. C., Hawkins, M. M., Bates, A. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1097 · Cited by 185 · see citing works
The Diagnosis and Management of Central Hypoadrenalism
Grossman, A. B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0982 · Cited by 187 · see citing works
Johannsson, G., Bergthorsdottir, R., Nilsson, A. G., Lennernas, H., Hedner, T., & Skrtic, S. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0170 · Cited by 173 · see citing works
Self-citationThe approach to the adult with newly diagnosed adrenal insufficiency
Arlt, W. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0032 · Cited by 165 · see citing works
Woodcock, T., Barker, P., Daniel, S., Fletcher, S., Wass, J. A. H., Tomlinson, J. W., Misra, U., Dattani, M., Arlt, W., & Vercueil, A. (2020) · Anaesthesia · doi:10.1111/anae.14963 · Cited by 163 · see citing works
“Excess mortality in both men and women was attributable to cardiovascular, malignant and infectious diseases [19].”
BackgroundWoods, C. P., Argese, N., Chapman, M., Boot, C., Webster, R., Dabhi, V., Grossman, A. B., Toogood, A. A., Arlt, W., Stewart, P. M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0608 · Cited by 152 · see citing works
Adrenal insufficiency: etiology, diagnosis and treatment
Neary, N., & Nieman, L. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328338f608 · Cited by 140 · see citing works
Øksnes, M., Björnsdottir, S., Isaksson, M., Methlie, P., Carlsen, S., Nilsen, R. M., Broman, J.-E., Triebner, K., Kämpe, O., Hulting, A.-L., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4253 · Cited by 134 · see citing works
The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135 · see citing works
Adrenal crisis: prevention and management in adult patients
Dineen, R., Thompson, C. J., & Sherlock, M. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819848218 · Cited by 123 · see citing works
Whitaker, M. J., Debono, M., Huatan, H., Merke, D. P., Arlt, W., & Ross, R. J. (2014) · Clinical Endocrinology · doi:10.1111/cen.12316 · Cited by 121 · see citing works
Grossman, A., Johannsson, G., Quinkler, M., & Zelissen, P. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0450 · Cited by 119 · see citing works
Self-citationBancos, I., Hazeldine, J., Chortis, V., Hampson, P., Taylor, A. E., Lord, J. M., & Arlt, W. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0969 · Cited by 110 · see citing works
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency
Arlt, W., Baldeweg, S. E., Pearce, S. H. S., & Simpson, H. L. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0361 · Cited by 107 · see citing works
Forss, M., Batcheller, G., Skrtic, S., & Johannsson, G. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-8 · Cited by 109 · see citing works
Self-citationMazziotti, G., Formenti, A. M., Frara, S., Roca, E., Mortini, P., Berruti, A., & Giustina, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0154 · Cited by 96 · see citing works
El-Maouche, D., Hargreaves, C. J., Sinaii, N., Mallappa, A., Veeraraghavan, P., & Merke, D. P. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00208 · Cited by 93 · see citing works
Exploring inpatient hospitalizations and morbidity in patients with adrenal insufficiency
Stewart, P. M., Biller, B. M. K., Marelli, C., Gunnarsson, C., Ryan, M. P., & Johannsson, G. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2221 · Cited by 90 · see citing works
Self-citationDynamic Pituitary-Adrenal Interactions in Response to Cardiac Surgery*
Gibbison, B., Spiga, F., Walker, J. J., Russell, G. M., Stevenson, K., Kershaw, Y., Zhao, Z., Henley, D., Angelini, G. D., & Lightman, S. L. (2015) · Critical Care Medicine · doi:10.1097/ccm.0000000000000773 · Cited by 87 · see citing works
Gibbison, B., Angelini, G. D., & Lightman, S. L. (2013) · British Journal of Anaesthesia · doi:10.1093/bja/aet077 · Cited by 87 · see citing works
Increased mortality risk in patients with primary and secondary adrenal insufficiency
Ngaosuwan, K., Johnston, D. G., Godsland, I. F., Cox, J., Majeed, A., Quint, J. K., Oliver, N., & Robinson, S. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab096 · Cited by 77 · see citing works
Björnsdottir, S., Sundström, A., Ludvigsson, J. F., Blomqvist, P., Kämpe, O., & Bensing, S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3561 · Cited by 70 · see citing works
Smans, L. C. C. J., Souverein, P. C., Leufkens, H. G. M., Hoepelman, A. I. M., & Zelissen, P. M. J. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0879 · Cited by 70 · see citing works
Quinkler, M., Ekman, B., Zhang, P., Isidori, A. M., Murray, R. D., & on behalf of the EU‐AIR Investigators (2018) · Clinical Endocrinology · doi:10.1111/cen.13609 · Cited by 71 · see citing works
Pofi, R., Feliciano, C., Sbardella, E., Argese, N., Woods, C. P., Grossman, A. B., Jafar-Mohammadi, B., Gleeson, H., Lenzi, A., Isidori, A. M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00529 · Cited by 67 · see citing works
Increased Infection Risk in Addison’s Disease and Congenital Adrenal Hyperplasia
Tresoldi, A. S., Sumilo, D., Perrins, M., Toulis, K. A., Prete, A., Reddy, N., Wass, J. A. H., Arlt, W., & Nirantharakumar, K. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz006 · Cited by 65 · see citing works
Ruiz-Babot, G., Balyura, M., Hadjidemetriou, I., Ajodha, S. J., Taylor, D. R., Ghataore, L., Taylor, N. F., Schubert, U., Ziegler, C. G., Storr, H. L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.003 · Cited by 65 · see citing works
Adrenal Crises in Children: Perspectives and Research Directions
Rushworth, R. L., Torpy, D. J., Stratakis, C. A., & Falhammar, H. (2018) · Hormone Research in Paediatrics · doi:10.1159/000481660 · Cited by 60 · see citing works
How to avoid precipitating an acute adrenal crisis
Wass, J. A. H., & Arlt, W. (2012) · BMJ · doi:10.1136/bmj.e6333 · Cited by 61 · see citing works
Therapeutic management of adrenal insufficiency
Hahner, S., & Allolio, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.009 · Cited by 61 · see citing works
Filipsson, H., & Johannsson, G. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0319 · Cited by 50 · see citing works
Self-citationMeyer, G., Hackemann, A., Reusch, J., & Badenhoop, K. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0158 · Cited by 50 · see citing works
Subcutaneous pulsatile glucocorticoid replacement therapy
Russell, G. M., Durant, C., Ataya, A., Papastathi, C., Bhake, R., Woltersdorf, W., & Lightman, S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12470 · Cited by 49 · see citing works
Burger‐Stritt, S., Kardonski, P., Pulzer, A., Meyer, G., Quinkler, M., & Hahner, S. (2018) · Clinical Endocrinology · doi:10.1111/cen.13608 · Cited by 44 · see citing works
Adrenal Steroidogenesis after B Lymphocyte Depletion Therapy in New-Onset Addison's Disease
Pearce, S. H. S., Mitchell, A. L., Bennett, S., King, P., Chandran, S., Nag, S., Chen, S., Smith, B. R., Isaacs, J. D., & Vaidya, B. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1680 · Cited by 41 · see citing works
Gan, E. H., MacArthur, K., Mitchell, A. L., Hughes, B. A., Perros, P., Ball, S. G., James, R. A., Quinton, R., Chen, S., Furmaniak, J., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2449 · Cited by 36 · see citing works
Chantzichristos, D., Persson, A., Eliasson, B., Miftaraj, M., Franzén, S., Bergthorsdottir, R., Gudbjörnsdottir, S., Svensson, A.-M., & Johannsson, G. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0657 · Cited by 30 · see citing works
Self-citationEkman, B., Fitts, D., Marelli, C., Murray, R. D., Quinkler, M., & Zelissen, P. M. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-40 · Cited by 31 · see citing works
Lightman, S., & Terry, J. R. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70182-7 · Cited by 28 · see citing works
Saving lives of patients with adrenal insufficiency: a pan‐ <scp>E</scp> uropean initiative?
Quinkler, M., Hahner, S., Johannsson, G., & Stewart, P. M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12378 · Cited by 22 · see citing works
Self-citationWatanabe, T., Ozawa, A., Ishii, S., Tomaru, T., Shibusawa, N., Saito, T., Yamada, E., Horiguchi, K., Nakajima, Y., Matsumoto, S., et al. (2018) · Endocrine Journal · doi:10.1507/endocrj.ej16-0387 · Cited by 22 · see citing works
Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments
Johannsson, G., Skrtic, S., Lennernäs, H., Quinkler, M., & Stewart, P. M. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.925865 · Cited by 21 · see citing works
Self-citationRousseau, E., Joubert, M., Trzepla, G., Parienti, J. J., Freret, T., Vanthygem, M. C., Desailloud, R., Lefebvre, H., Coquerel, A., Reznik, Y., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135975 · Cited by 20 · see citing works
Novel methods in adrenal research: a metabolomics approach
Papathomas, T. G., Sun, N., Chortis, V., Taylor, A. E., Arlt, W., Richter, S., Eisenhofer, G., Ruiz-Babot, G., Guasti, L., & Walch, A. K. (2019) · Histochemistry and Cell Biology · doi:10.1007/s00418-019-01772-w · Cited by 14 · see citing works
Bäcklund, N., Lundstedt, S., Tornevi, A., Wihlbäck, A.-C., Olsson, T., Dahlqvist, P., & Brattsand, G. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad763 · Cited by 13 · see citing works
“Adrenal insufficiency (AI) is a rare condition causing substantial morbidity, increased mortality, and risk of fatal acute adrenal crises (1-3).”
Background
- Authors
- Bergthorsdottir, R., Leonsson-Zachrisson, M., Odén, A., & Johannsson, G.
- Affiliations
- Sahlgrenska University Hospital (SE)
- Department of Endocrinology (R.B., M.L.-Z., G.J.), Sahlgrenska University Hospital, SE-413 45 Gothenburg, Sweden
- Department of Mathematical Sciences (A.O.), Chalmers University of Technology, SE-412 96 Gothenburg, Sweden
- Corresponding author
- Bergthorsdottir, Ragnhildur
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-12-01
- Volume
- 91
- Issue
- 12
- Pages
- 4849-4853
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2132382547
- Semantic Scholar
- 6bcbe4e09c391e0932d182ad464f978944049fc9
- Cited by
- 490
- References
- 32
- Citations by year
- 2026: 13 · 2025: 21 · 2024: 27 · 2023: 24 · 2022: 30 · 2021: 28 · 2020: 37 · 2019: 32 · 2018: 23 · 2017: 31 · 2016: 36 · 2015: 23 · 2014: 46 · 2013: 25 · 2012: 19
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Chalmers Publication Library (Chalmers University of Technology) (submittedVersion)
- Chalmers Research (Chalmers University of Technology) (submittedVersion)
- Funders
- Sahlgrenska Universitetssjukhuset
- Socialstyrelsen
- Sahlgrenska Akademin
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- Addison's disease, premature mortality, all-cause mortality, excess mortality, cardiovascular disease, cancer, infectious diseases, diabetes mellitus, sex differences
- MeSH terms
- Addison Disease, Adult, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Sweden, Cohort Studies, Comorbidity, Odds Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review